Primary Care POC Diagnostics Market to Reach $26B by 2030, Driven by Efficiency Gains and Growth in Key Segments
-
The primary care POC diagnostics market is projected to reach $26.17 billion by 2030, with a CAGR of 6.5% from 2023-2030.
-
Key drivers include increased efficiency in clinical operations, cost and time savings from waived CLIA tests, and growth in segments like glucose testing and lipid testing.
-
Infectious disease testing was the largest product segment in 2022 with 26.4% market share. Lipid testing is expected to see significant adoption growth.
-
North America, especially the U.S., leads the global market due to innovative products, increased awareness, and rising home healthcare demand.
-
Future outlook is positive despite challenges like overlap in methods, with advancements in technology and evolving healthcare practices driving further expansion.